13F Pro

SEC Form 4 reporting owner

Gao Hanlin

Gao Hanlin has filed 21 Form 4 transactions reported between November 24, 2025 and September 2, 2026, as Chief Scientific Officer of Fulgent Genetics, Inc..

Name as filed: Gao Hanlin

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$173K
7 lines
Companies
1
with Form 4 filings
Latest transaction
Sep 2, 2026
transaction date

Roles and reported holdings

  • FLGTFulgent Genetics, Inc.
    Nov 24, 2025 – Sep 2, 2026

    Chief Scientific Officer

    Held directly986,117 sh as of Sep 2, 2026 · Form 4

    24 months: $173K sold

Transaction history

All 21 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 2, 2026FLGTChief Scientific OfficerOpen-market saleCode S · direct1,673$33K@ $19.66Form 4
Aug 27, 2026FLGTChief Scientific OfficerOpen-market saleCode S · direct939$19K@ $19.91Form 4
Jul 26, 2026FLGTChief Scientific OfficerShares withheld for tax or exercise priceCode F · direct1,645$32K@ $19.67Form 4
Jun 2, 2026FLGTChief Scientific OfficerOpen-market saleCode S · direct1,688$30K@ $17.89Form 4
May 27, 2026FLGTChief Scientific OfficerOpen-market saleCode S · direct945$17K@ $17.60Form 4
Apr 26, 2026FLGTChief Scientific OfficerShares withheld for tax or exercise priceCode F · direct1,645$27K@ $16.31Form 4
Mar 1, 2026FLGTChief Scientific OfficerShares withheld for tax or exercise priceCode F · direct6,410$98K@ $15.33Form 4
Mar 1, 2026FLGTChief Scientific OfficerShares withheld for tax or exercise priceCode F · direct1,018$16K@ $15.33Form 4
Feb 26, 2026FLGTChief Scientific OfficerShares withheld for tax or exercise priceCode F · direct897$22K@ $24.76Form 4
Feb 24, 2026FLGTChief Scientific OfficerGrant or awardCode A · direct26,661—Form 4
Feb 24, 2026FLGTChief Scientific OfficerShares withheld for tax or exercise priceCode F · direct8,149$188K@ $23.09Form 4
Feb 24, 2026FLGTChief Scientific OfficerShares withheld for tax or exercise priceCode F · direct4,661$108K@ $23.09Form 4
Feb 24, 2026FLGTChief Scientific OfficerShares withheld for tax or exercise priceCode F · direct2,489$57K@ $23.09Form 4
Feb 24, 2026FLGTChief Scientific OfficerGrant or awardCode A · direct22,806—Form 4
Feb 24, 2026FLGTChief Scientific OfficerGrant or awardCode A · direct12,762—Form 4
Feb 24, 2026FLGTChief Scientific OfficerGrant or awardCode A · direct4,891—Form 4
Feb 23, 2026FLGTChief Scientific OfficerShares withheld for tax or exercise priceCode F · direct403$9K@ $23.01Form 4
Jan 26, 2026FLGTChief Scientific OfficerShares withheld for tax or exercise priceCode F · direct1,331$37K@ $27.53Form 4
Dec 2, 2025FLGTChief Scientific OfficerOpen-market saleCode S · direct1,075$30K@ $28.33Form 4
Nov 28, 2025FLGTChief Scientific OfficerOpen-market saleCode S · direct943$28K@ $29.57Form 4
Nov 24, 2025FLGTChief Scientific OfficerOpen-market saleCode S · direct535$16K@ $30.47Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.